The Relative Strength (RS) Rating for Envista Holdings climbed into a higher percentile Monday, as it got a lift from 69 to 73.
When To Sell Stocks To Lock In Profits And Minimize Losses
This exclusive rating from Investor's Business Daily tracks market leadership with a 1 (worst) to 99 (best) score. The rating shows how a stock's price movement over the trailing 52 weeks holds up against all the other stocks in our database.
Over 100 years of market history reveals that the best stocks often have an RS Rating of over 80 as they begin their biggest runs. See if Envista Holdings can continue to show renewed price strength and hit that benchmark.
Envista Holdings is working on a double bottom with a 22.68 buy point. See if the stock can clear the breakout price in heavy volume.
Taking a look at top and bottom line numbers, Envista Holdings has posted rising EPS growth in each of the last three reports. Revenue growth has been less impressive, coming in at -1% last quarter.
Envista Holdings earns the No. 15 rank among its peers in the Medical-Systems/Equipment industry group. iRadimed, Brainsway ADR and Masimo are among the top 5 highly rated stocks within the group.
This article was created automatically with Stats Perform's Wordsmith software using data and article templates supplied by Investor's Business Daily. An IBD journalist may have edited the article.
RELATED:
Stocks With Rising Relative Strength Ratings
Why Should You Use IBD's Relative Strength Rating?
How Relative Strength Line Can Help You Judge A Stock
Ready To Grow Your Investing Skills? Join An IBD Meetup Group!
